On Friday, Shares of General Electric Company (NYSE:GE), gained 1.09% to $24.95.
General Electric Company declared three winners in the final phase of its GHG Ecomagination Innovation Challenge, with the aim of commercializing technology to reduce environmental impact from production in Canada’s Oil Sands. The final phase identified two winners from the US and one from France , with technologies best responding to the challenge of improving the efficiency of steam generation in Steam Assisted Gravity Drainage (SAGD) based operations.
The winners are Sid Abma , Sidel Systems USA , Inc., U.S.A. , Sylvain Lalot, UVHC, France , and Sumon K. Sinha , SINHATECH, U.S.A. The selected Winners have the opportunity to create co-development plans with GE and other potential partners that will draw on a $475,000 CAD directed development grant pool.
GE’s GHG Ecomagination Innovation Challenge targets two of the biggest opportunities to reduce GHG in the oil sands: higher value use of low-grade heat and improved efficiency of steam generation. The second topic, which launched in February 2015 , aims to improve the efficiency of once through steam generation (OTSG) technology, and thereby lower GHG emissions and reduce the environmental impact of oil extraction from the Canadian Oil Sands. OTSGs generate steam for use in SAGD production which is the most common method of recover
General Electric Company (GE) operates as an infrastructure and financial services company worldwide. The company’s Power and Water segment offers gas, steam and aeroderivative turbines, nuclear reactors, generators, combined cycle systems, controls, and related services; wind turbines; and water treatment services and equipment.
Shares of Twenty-First Century Fox, Inc. (NASDAQ:FOXA), declined -0.23% to $26.45, during its last trading session.
The National Geographic Society and 21st Century Fox declared that they have reached a contract to expand their highly successful 18-year partnership through which they have owned and operated the properties in National Geographic Channels, a joint venture of domestic and international cable television channels which together reach more than 500 million households globally.
The National Geographic Society is a 501(c)(3) non-profit organization focused on its mission of science, exploration and education. Consideration for the transaction is valued at $725 million. As a result, the Society’s endowment will significantly improvement to nearly $1 billion. The new entity will be owned 73 percent by 21st Century Fox and 27 percent by The National Geographic Society with a shared governance structure and equal representation on the board of directors. The Board Chair will alternate annually, with Gary Knell, National Geographic Society President and CEO, serving as the Board’s first Chairman.
The new expanded joint venture will operate as National Geographic Partners and will combine the National Geographic television channels with National Geographic’s other media and consumer-oriented assets, counting: National Geographic magazines; National Geographic Studios; related digital and social media platforms; books; maps; children’s media; and ancillary activities, counting travel, location-based entertainment, archival sales, catalog, licensing and ecommerce businesses. Combining these assets into one organization will create greater opportunities to pursue National Geographic’s mission of increasing knowledge through science, exploration and research.
Twenty-First Century Fox, Inc. operates as a diversified media and entertainment company worldwide. It operates through Cable Network Programming; Television; Filmed Entertainment; and Other, Corporate and Eliminations segments.
Finally, Teva Pharmaceutical Industries Limited (NYSE:TEVA), ended its last trade with 2.61% gain, and closed at $63.66.
IBM (IBM) Watson Health and Teva Pharmaceutical Industries Limited declared that Teva has been selected as its first Foundational Life Sciences Partner for the Watson Health Cloud. As part of this new planned partnership, Teva becomes the first global pharmaceutical company to tap the power of the Watson Health Cloud to benefit patients and healthcare providers across geographies.
Teva has chosen the IBM Watson Health Cloud as a preferred global technology platform and aims to build solutions designed to assist millions of individuals worldwide with complex and chronic conditions such as asthma, pain, migraine and neurodegenerative diseases. In addition, a joint Teva-IBM Research team will deploy Big Data and machine learning technology to create disease models and advanced therapeutic solutions.
“Teva is actively exploring the e-health evolution with a strong focus on fulfilling unmet and emerging patients’ needs. The IBM Watson Health Cloud provides a strong foundation on which we can realize this vision,” said Guy Hadari, SVP and CIO for Teva Pharmaceutical Industries Ltd. “By building on the Watson Health Cloud, we believe Teva will be in a unique position to put the best information and insights in the hands of physicians, care teams and patients, to empower treatment optimization for individuals and populations across the spectrum of acute and chronic conditions. Watson holds promise to provide Teva with better insights, real-time feedback and options for clinicians to consider to improve patient care.”
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic, specialty, and other pharmaceutical products worldwide. The company operates in two segments, Generic Medicines and Specialty Medicines.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
